User profiles for Peter R Schofield
Peter R SchofieldNeuroscience Research Australia Verified email at neura.edu.au Cited by 66290 |
Association of missense and 5′-splice-site mutations in tau with the inherited dementia FTDP-17
Thirteen families have been described with an autosomal dominantly inherited dementia
named frontotemporal dementia and parkinsonism linked to chromosome 17 (FTDP-17) 1 , 2 , 3 …
named frontotemporal dementia and parkinsonism linked to chromosome 17 (FTDP-17) 1 , 2 , 3 …
Clinical and biomarker changes in dominantly inherited Alzheimer's disease
…, JM Ringman, MN Rossor, PR Schofield… - … England Journal of …, 2012 - Mass Medical Soc
Background The order and magnitude of pathologic processes in Alzheimer's disease are
not well understood, partly because the disease develops over many years. Autosomal …
not well understood, partly because the disease develops over many years. Autosomal …
Sequence and functional expression of the GABAA receptor shows a ligand-gated receptor super-family
PR Schofield, MG Darlison, N Fujita, DR Burt… - Nature, 1987 - nature.com
Amino-acid sequences derived from complementary DMAs encoding the α- and β-subunits
of the GAB A/ benzo diazepine receptor from bovine brain show homology with other ligand-…
of the GAB A/ benzo diazepine receptor from bovine brain show homology with other ligand-…
Importance of a novel GABAA receptor subunit for benzodiazepine pharmacology
…, BD Shivers, S Ymer, H Kettenmann, PR Schofield… - Nature, 1989 - nature.com
NEUROTRANSMISSION effected by GABA (γ-aminobutyric acid) is predominantly mediated
by a gated chloride channel intrinsic to the GABA A receptor. This heterooligomeric receptor …
by a gated chloride channel intrinsic to the GABA A receptor. This heterooligomeric receptor …
Serum neurofilament dynamics predicts neurodegeneration and clinical progression in presymptomatic Alzheimer's disease
Neurofilament light chain (NfL) is a promising fluid biomarker of disease progression for
various cerebral proteopathies. Here we leverage the unique characteristics of the Dominantly …
various cerebral proteopathies. Here we leverage the unique characteristics of the Dominantly …
A soluble phosphorylated tau signature links tau, amyloid and the evolution of stages of dominantly inherited Alzheimer's disease
…, NR Graff-Radford, S Salloway, PR Schofield… - Nature medicine, 2020 - nature.com
Abstract Development of tau-based therapies for Alzheimer’s disease requires an understanding
of the timing of disease-related changes in tau. We quantified the phosphorylation state …
of the timing of disease-related changes in tau. We quantified the phosphorylation state …
[PDF][PDF] Genome scan meta-analysis of schizophrenia and bipolar disorder, part III: Bipolar disorder
Genome scans of bipolar disorder (BPD) have not produced consistent evidence for linkage.
The rank-based genome scan meta-analysis (GSMA) method was applied to 18 BPD …
The rank-based genome scan meta-analysis (GSMA) method was applied to 18 BPD …
The genetic architecture of the human cerebral cortex
INTRODUCTION The cerebral cortex underlies our complex cognitive capabilities.
Variations in human cortical surface area and thickness are associated with neurological, …
Variations in human cortical surface area and thickness are associated with neurological, …
Symptom onset in autosomal dominant Alzheimer disease: a systematic review and meta-analysis
…, JM Ringman, S Salloway, PR Schofield, R Sperling… - Neurology, 2014 - AAN Enterprises
Objective: To identify factors influencing age at symptom onset and disease course in
autosomal dominant Alzheimer disease (ADAD), and develop evidence-based criteria for …
autosomal dominant Alzheimer disease (ADAD), and develop evidence-based criteria for …
Spatial patterns of neuroimaging biomarker change in individuals from families with autosomal dominant Alzheimer's disease: a longitudinal study
…, S Salloway, AJ Saykin, PR Schofield… - The Lancet …, 2018 - thelancet.com
Background Models of Alzheimer's disease propose a sequence of amyloid β (Aβ) accumulation,
hypometabolism, and structural decline that precedes the onset of clinical dementia. …
hypometabolism, and structural decline that precedes the onset of clinical dementia. …